Nearly Half of Hepatitis C Patients on Medicaid Denied Coverage for Life-Saving Drugs, Researchers Report

Nov 30, 2015 | Alyssa Kitlas

New research from the University of Pennsylvania Perelman School of Medicine shows that 50% of Medicaid patients infected with chronic hepatitis C were denied coverage of newer, life-saving antiviral drugs prescribed by their doctors. Explanations included that the therapies were not considered “a medical necessity,” the patients had tested positive for alcohol/drugs, and other reasons. Researchers analyzed the hepatitis C prescriptions submitted to a large specialty pharmacy between November 2014 and April 2015 from 2,342 patients in Maryland, Delaware, Pennsylvania, and New Jersey. Overall, insurers denied 16% of prescriptions for the drugs, which includes the results of appeals that were filed after initial denials. The proportion of Medicaid denials, however, was much higher at 46%.

This is the first data of its kind to report delay and denial rates in a cohort of Medicaid, Medicare, and privately insured patients for the class of hepatitis C drugs known as direct-acting antiviral agents, therapies with very successful cure rates and high costs. For more information view the news release here.


About Alyssa Kitlas

More posts by Alyssa Kitlas

Related Posts

Ps24 posters d3 web

Day Three Highlights: 2024 Preparedness Summit

See highlights from day three of the 2024 Preparedness Summit.

Mar 27, 2024

Day Three Highlights: 2024 Preparedness Summit

D2 highlights web

Day Two Highlights: 2024 Preparedness Summit

See highlights from day two of the 2024 Preparedness Summit.

Mar 26, 2024

Day Two Highlights: 2024 Preparedness Summit

I Stock 1182682774
  • Adverse Childhood Experiences (ACEs)
  • Behavioral Health
  • Community Health
  • Injury and Violence Prevention

Seeking LHD Participants for an Intersectional Data...

With support from the Centers for Disease Control and Prevention, NACCHO is...

Mar 26, 2024 | Camille Adams

Seeking LHD Participants for an Intersectional Data...

PS24 1

Day One Highlights: 2024 Preparedness Summit

See highlights from day one of the 2024 Preparedness Summit.

Mar 25, 2024

Day One Highlights: 2024 Preparedness Summit

PS24 web
  • Tools & Resources
  • Training

Welcome to the 2024 Preparedness Summit!

Welcome to the 2024 Preparedness Summit.

Mar 25, 2024 | Beth Hess

Welcome to the 2024 Preparedness Summit!

Stakeholder Conference Call on the FDA Integrated Food...

You’re invited to join the call on April 2 to hear more.

Mar 25, 2024

Stakeholder Conference Call on the FDA Integrated Food...

Cover and Spine for MAPP 2 0 Handbook Copy Page 1
  • Mobilizing for Action through Planning and Partnerships (MAPP)
  • Performance Improvement
  • Workforce Development

Register to Attend a Mobilizing for Action through...

Registration is now open for NACCHO’s in-person Mobilizing for Action through...

Mar 23, 2024 | Andrea Grenadier

Register to Attend a Mobilizing for Action through...

Capitol bulding

Congress Releases Labor-HHS Bill in Final FY2024 Package

Early on March 21st, Congress released the final minibus package for Fiscal...

Mar 22, 2024 | Victoria Van de Vate

Congress Releases Labor-HHS Bill in Final FY2024 Package

Website New Episode w Special Guests
  • Press Release

National Association of County and City Health...

Local Public Health on the Hill Recap and Local Health Department Addresses the...

Mar 22, 2024

National Association of County and City Health...

Back to Top